ESR1 and breast carcinoma: The above results demonstrated that m‐PROTAC‐1, a novel type of PROTAC, could efficiently induce degradation of ERα in MCF‐7 cells, as confirmed by results of similar experiments conducted using T47D cells, another breast cancer‐derived cell line (Figure S3).